Business Standard
Home / India News / Lupin receives final approval for Carbidopa Tablets

Lupin receives final approval for Carbidopa Tablets

Image

Capital Market
Last Updated : Oct 25 2017 | 12:04 AM IST

From USFDA

Lupin has received final approval for its Carbidopa Tablets, 25 mg from the USFDA to market generic version of Aton Pharma Inc.'s Lodosyn Tablets, 25 mg.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Also Read

Lupin warns of more pricing pressure as fourth-quarter profit halves

Lupin warns of more pricing pressure as fourth-quarter profit halves

Drugmaker Lupin's profit halves as U.S. sales slump

Drugmaker Lupin's profit halves as U.S. sales slump

Lupin launches Bupropion Hydrochloride Extended Release Tablets

Lupin launches Bupropion Hydrochloride Extended Release Tablets

Lupin launches Desoximetasone Cream in United States

Lupin launches Desoximetasone Cream in United States

Lupin appoints Chief Corporate Development Officer

Lupin appoints Chief Corporate Development Officer

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 24 2017 | 6:30 PM IST

Explore News

Market LIVEMarket TodaySai Life Sciences IPOToss The Coin IPO AllotmentLatest News LIVEStocks To Watch TodayProcess to withdraw PF by ATMGold-Silver Price TodayIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon